Get the Stockscreener App
1.51
8.73%
-0.15
Medicinova Inc stock is traded at $1.51, with a volume of 1.93M.
It is down -8.73% in the last 24 hours and up +18.36% over the past month.
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
See More
Previous Close:
$1.66
Open:
$1.63
24h Volume:
1.93M
Relative Volume:
2.50
Market Cap:
$74.06M
Revenue:
$134.60K
Net Income/Loss:
$-11.81M
P/E Ratio:
-6.2682
EPS:
-0.2409
Net Cash Flow:
$-10.05M
1W Performance:
+25.73%
1M Performance:
+18.36%
6M Performance:
+0.33%
1Y Performance:
-8.73%
1-Day Range:
$1.51
$1.69
1-Week Range:
$1.168
$1.96
52-Week Range:
$1.13
$2.55
Medicinova Inc Stock (MNOV) Company Profile
Name
Medicinova Inc
Sector
Industry
Phone
858-373-1500
Address
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Compare MNOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
1.51 | 81.42M | 134.60K | -11.81M | -10.05M | -0.2409 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.80 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.61 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.11 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-21 | Initiated | Maxim Group | Buy |
| Mar-25-19 | Resumed | B. Riley FBR | Buy |
| Mar-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Apr-18-17 | Initiated | Credit Suisse | Outperform |
| Jan-04-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-24-12 | Downgrade | MLV & Co | Buy → Hold |
| Oct-18-11 | Reiterated | MLV Capital | Buy |
| Jun-22-11 | Initiated | Global Hunter Securities | Buy |
| May-12-10 | Initiated | Wedbush | Outperform |
| Nov-12-08 | Reiterated | Ladenburg Thalmann | Buy |
| May-15-08 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jul-09-07 | Initiated | Punk, Ziegel & Co | Buy |
View All
Medicinova Inc Stock (MNOV) Latest News
Is MediciNova Inc. stock a contrarian buyEarnings Overview Summary & Fast Exit and Entry Trade Guides - newser.com
Will MediciNova Inc. stock maintain growth storyWeekly Stock Summary & Daily Stock Trend Reports - newser.com
What’s next for MediciNova Inc. stock price2025 Trade Ideas & Weekly Setup with ROI Potential - newser.com
What Fibonacci levels say about MediciNova Inc. rebound2025 Earnings Impact & Weekly Market Pulse Updates - newser.com
Market reaction to MediciNova Inc.’s recent newsJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
Key resistance and support levels for MediciNova Inc.Forecast Cut & Free Technical Pattern Based Buy Signals - newser.com
What dividend safety score for MediciNova Inc. stockStop Loss & Momentum Based Trading Signals - newser.com
3 Penny Stocks With Market Caps Over $80M To Consider - simplywall.st
Trend analysis for MediciNova Inc. this weekJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
How currency fluctuations impact MediciNova Inc. stockWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com
Applying Elliott Wave Theory to MediciNova Inc.Trend Reversal & Weekly Setup with High ROI Potential - newser.com
Will MediciNova Inc. stock remain a Wall Street favorite2025 Stock Rankings & Weekly Breakout Stock Alerts - newser.com
MediciNova Research Sparks New Hope for Atherosclerosis Therapy - StocksToTrade
MediciNova’s Breakthrough Strategy in Atherosclerosis Treatment - timothysykes.com
Applying big data sentiment scoring on MediciNova Inc.Earnings Risk Summary & Safe Entry Zone Tips - newser.com
Developing predictive dashboards with MediciNova Inc. dataGap Up & Low Risk High Win Rate Stock Picks - newser.com
MediciNova, Inc. (MNOV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Will MediciNova Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Verified Technical Signals - newser.com
MediciNova Advances Atherosclerosis Research with Novel Therapeutic Strategy - StocksToTrade
MediciNova’s New Research Drives Strategic Focus on Cholesterol Metabolism - timothysykes.com
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis - Yahoo Finance
MediciNova Stock Surge: Unveiling the Latest Development - timothysykes.com
MediciNova (MNOV) Analyst Ratings: Consistent 'Buy' Rating Maint - GuruFocus
D. Boral Capital Maintains MediciNova (MNOV) Buy Recommendation - Nasdaq
MediciNova Stock Rockets 85% After-Hours On Promising Heart Study — Traders Hope For ‘Big Green Candle’ - Stocktwits
Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading? - Benzinga
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in ... - Enidnews.com
MediciNova, Inc. Publishes Research on MN-002's Potential in Atherosclerosis Treatment in Journal of Atherosclerosis and Thrombosis - Quiver Quantitative
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication - The Manila Times
MediciNova (NASDAQ: MNOV) publishes tipelukast data: MN-002 enhances cholesterol efflux - Stock Titan
RMN.BE interactive stock chart | Medicinova Inc. R stock - Yahoo! Finance Singapore
Medicinova Inc Stock (MNOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):